Drug-Drug Interaction Networks:

• Drug-Drug Interaction: Palifermin interacts with Bendamustine
• Drug-Drug Interaction Description: Increases toxicity of bendamustine. Should not be administered within a 24 hour time period of antineoplastic agent administration.
• First Drug ID: DB00039
• Drug Name: Palifermin
• Drug : DB00039 Palifermin ['FGF-7', 'Fibroblast growth factor- 7', 'HBGF-7', 'Keratinocyte growth factor precursor', 'KGF']



• Second Drug ID: DB06769
• Interacting Drug Name: Bendamustine
• Drug : DB06769 Bendamustine



---

• Drug-Drug Interaction: Palifermin interacts with Pralatrexate
• Drug-Drug Interaction Description: Increases the toxicity of pralatrexate. Avoid concomitant therapy or do not use palifermin within 24 hours after administration of pralatrexate.
• First Drug ID: DB00039
• Drug Name: Palifermin
• Drug : DB00039 Palifermin ['FGF-7', 'Fibroblast growth factor- 7', 'HBGF-7', 'Keratinocyte growth factor precursor', 'KGF']



• Second Drug ID: DB06813
• Interacting Drug Name: Pralatrexate
• Drug : DB06813 Pralatrexate Pralatrexate ['PDX']



---